Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 5
2016 1
2017 1
2019 1
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Data collection and interpretation.
Citerio G, Park S, Schmidt JM, Moberg R, Suarez JI, Le Roux PD; Second Neurocritical Care Research Conference Investigators. Citerio G, et al. Neurocrit Care. 2015 Jun;22(3):360-8. doi: 10.1007/s12028-015-0139-4. Neurocrit Care. 2015. PMID: 25846711 Free article. Review.
Multi-modality neuro-monitoring: conventional clinical trial design.
Georgiadis AL, Palesch YY, Zygun D, Hemphill JC 3rd, Robertson CS, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators. Georgiadis AL, et al. Neurocrit Care. 2015 Jun;22(3):369-77. doi: 10.1007/s12028-015-0134-9. Neurocrit Care. 2015. PMID: 25832350 Review.
Global monitoring in the neurocritical care unit.
Olson DM, Andrew Kofke W, O'Phelan K, Gupta PK, Figueroa SA, Smirnakis SM, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators. Olson DM, et al. Neurocrit Care. 2015 Jun;22(3):337-47. doi: 10.1007/s12028-015-0132-y. Neurocrit Care. 2015. PMID: 25846709 Review.
Alternative clinical trial design in neurocritical care.
Lazaridis C, Maas AI, Souter MJ, Martin RH, Chesnut RM, DeSantis SM, Sung G, Leroux PD, Suarez JI; Second Neurocritical Care Research Conference Investigators. Lazaridis C, et al. Neurocrit Care. 2015 Jun;22(3):378-84. doi: 10.1007/s12028-015-0135-8. Neurocrit Care. 2015. PMID: 25894451 Review.
Regional brain monitoring in the neurocritical care unit.
Frontera J, Ziai W, O'Phelan K, Leroux PD, Kirkpatrick PJ, Diringer MN, Suarez JI; Second Neurocritical Care Research Conference Investigators. Frontera J, et al. Neurocrit Care. 2015 Jun;22(3):348-59. doi: 10.1007/s12028-015-0133-x. Neurocrit Care. 2015. PMID: 25832349 Review.
A Treatment Algorithm for High-Tone Pelvic Floor Dysfunction.
Torosis M, Carey E, Christensen K, Kaufman MR, Kenton K, Kotarinos R, Lai HH, Lee U, Lowder JL, Meister M, Spitznagle T, Wright K, Ackerman AL. Torosis M, et al. Obstet Gynecol. 2024 Apr 1;143(4):595-602. doi: 10.1097/AOG.0000000000005536. Epub 2024 Feb 22. Obstet Gynecol. 2024. PMID: 38387036 Free PMC article.
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.
Terry MB, Michels KB, Brody JG, Byrne C, Chen S, Jerry DJ, Malecki KMC, Martin MB, Miller RL, Neuhausen SL, Silk K, Trentham-Dietz A; Breast Cancer and the Environment Research Program (BCERP). Terry MB, et al. Breast Cancer Res. 2019 Aug 20;21(1):96. doi: 10.1186/s13058-019-1168-2. Breast Cancer Res. 2019. PMID: 31429809 Free PMC article. Review.
Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.
Karaa A, Bertini E, Carelli V, Cohen BH, Enns GM, Falk MJ, Goldstein A, Gorman GS, Haas R, Hirano M, Klopstock T, Koenig MK, Kornblum C, Lamperti C, Lehman A, Longo N, Molnar MJ, Parikh S, Phan H, Pitceathly RDS, Saneto R, Scaglia F, Servidei S, Tarnopolsky M, Toscano A, Van Hove JLK, Vissing J, Vockley J, Finman JS, Brown DA, Shiffer JA, Mancuso M; MMPOWER-3 Trial Investigators. Karaa A, et al. Neurology. 2023 Jul 18;101(3):e238-e252. doi: 10.1212/WNL.0000000000207402. Epub 2023 Jun 2. Neurology. 2023. PMID: 37268435 Free PMC article. Clinical Trial.
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI; MGTX study group. Lee I, et al. Neurology. 2020 Aug 11;95(6):e755-e766. doi: 10.1212/WNL.0000000000010031. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611638 Free PMC article. Clinical Trial.
15 results